Related references
Note: Only part of the references are listed.Pathophysiology of atrial fibrillation and chronic kidney disease
Wern Yew Ding et al.
CARDIOVASCULAR RESEARCH (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Patients With Chronic Kidney Disease and Atrial Fibrillation
Amber Makani et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey
Tatjana S. Potpara et al.
EUROPACE (2020)
Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease
Matthew R. Weir et al.
AMERICAN HEART JOURNAL (2020)
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
Yi-Hsin Chan et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
John W. Stanifer et al.
CIRCULATION (2020)
Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation
James B. Wetmore et al.
STROKE (2020)
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoina Hemodialysis
Craig Coleman et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Yi-Hsin Chan et al.
CHEST (2019)
Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease
Shang-Hung Chang et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation
So-Ryoung Lee et al.
STROKE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
So-Ryoung Lee et al.
YONSEI MEDICAL JOURNAL (2019)
Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany - A retrospective cohort study
Hendrik Bonnemeier et al.
IJC HEART & VASCULATURE (2019)
Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
Emma Kirstine Laugesen et al.
THROMBOSIS JOURNAL (2019)
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
Jung-Im Shin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study
Hee Tae Yu et al.
STROKE (2018)
Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease
Felix Yang et al.
HEART (2017)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis
Giuseppe Ando et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Network meta-analysis: application and practice using Stata
Sungryul Shim et al.
EPIDEMIOLOGY AND HEALTH (2017)
Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation
Freddy Del-Carpio Munoz et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial
Erin A. Bohula et al.
CIRCULATION (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients with renal dysfunction
Ki Hong Lee et al.
EUROPACE (2015)
Risk of Bleeding With Dabigatran in Atrial Fibrillation
Inmaculada Hernandez et al.
JAMA INTERNAL MEDICINE (2015)
Network meta-analysis
Ian R. White
STATA JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Visualizing assumptions and results in network meta-analysis: The network graphs package
Anna Chaimani et al.
STATA JOURNAL (2015)
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis
Ziad Hijazi et al.
CIRCULATION (2014)
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease A Nationwide Observational Cohort Study
Anders Nissen Bonde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
A hands-on practical tutorial on performing meta-analysis with Stata
Anna Chaimani et al.
EVIDENCE-BASED MENTAL HEALTH (2014)
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
Masatsugu Hori et al.
CIRCULATION JOURNAL (2012)
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
Jonas Bjerring Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
Hiroshi Watanabe et al.
AMERICAN HEART JOURNAL (2009)
Share Paper
